We also demonstrated that the selective COX-2 inhibitor celecoxib, at a concentration (0.5 μM) that inhibited PGE2 production by > 90% in mouse CRC cell lines (Fig. 4a) and did not display toxicity (Online Resource 3—supplementary fig. The gene discussed is PTGS2; the disease is colorectal carcinoma.